Effect of Today’s Value Orientation on Medtech Innovators
John Hernandez, Vice President of Global Health Economics and Outcomes Research at Abbott Vascular, talks about the current focus on value in the medtech field and its implications to large companies and start-ups.
Incremental Versus Breakthrough Innovation
John Hernandez, Vice President of Global Health Economics and Outcomes Research at Abbott Vascular, comments on the changing condition for advancing incremental and breakthrough medtech innovations to market.
Changes in the US Reimbursement Landscape
John Hernandez, Vice President of Global Health Economics and Outcomes Research at Abbott Vascular, highlights a few important changes in the U.S. reimbursement environment stimulated by the Affordable Care Act.
Factors to Consider When Establishing Reimbursement in the US
John Hernandez, Vice President of Global Health Economics and Outcomes Research at Abbott Vascular, explains how getting a new technology reimbursed is an evidence-based process, but also depends on the support the company can engender.
Timeline for Establishing Reimbursement in the US
John Hernandez, Vice President of Global Health Economics and Outcomes Research at Abbott Vascular, outlines a rough timeline for obtaining reimbursement codes and payment categories for a new technology in the U.S.
New Technology Payment Mechanisms Outside the US
John Hernandez, Vice President of Global Health Economics and Outcomes Research at Abbott Vascular, comments on useful payment mechanisms for new technologies in German, France, and the United Kingdom.
Reimbursement from US Private Payers
John Hernandez, Vice President of Global Health Economics and Outcomes Research at Abbott Vascular, describes the complex network of private payers in the U.S. and comments on the implications to innovators.
Reimbursement Dossiers
John Hernandez, Vice President of Global Health Economics and Outcomes Research at Abbott Vascular, comments on the usefulness of reimbursement dossiers in the current environment and when and why to develop one.
Value-Based Payment Programs
John Hernandez, Vice President of Global Health Economics and Outcomes Research at Abbott Vascular, provides an overview of value-based payment approaches.
Risk Sharing
John Hernandez, Vice President of Global Health Economics and Outcomes Research at Abbott Vascular, provides an overview of risk sharing as a payment approach.
Value Analysis Committees
John Hernandez, Vice President of Global Health Economics and Outcomes Research at Abbott Vascular, highlights a few important points about working with value analysis committees.